Your browser doesn't support javascript.
Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report.
Miyamoto, Kyohei; Koizumi, Yusuke; Tamura, Shinobu; Nakashima, Tsuyoshi; Kobai, Kaori; Tanaka, Rikako; Shibata, Mami; Shima, Nozomu; Nemoto, Shigeki; Fukumoto, Nobu; Kato, Seiya.
  • Miyamoto K; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. Electronic address: gomadofu@wakayama-med.ac.jp.
  • Koizumi Y; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Tamura S; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Hematology/Oncology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Nakashima T; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Kobai K; Department of Anesthesiology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Tanaka R; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Shibata M; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Shima N; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Nemoto S; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Fukumoto N; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
  • Kato S; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
J Infect Chemother ; 28(1): 99-102, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1446857
ABSTRACT
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Case report / Cohort study / Prognostic study Limits: Adult / Female / Humans Country/Region as subject: Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Case report / Cohort study / Prognostic study Limits: Adult / Female / Humans Country/Region as subject: Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2022 Document Type: Article